Pulmonary Carcinoid Surface Receptor Modulation Using Histone Deacetylase Inhibitors

Pulmonary Carcinoid Surface Receptor Modulation Using Histone Deacetylase Inhibitors

Pulmonary carcinoids are a type of neuroendocrine tumor (NET) accounting for 1&#8722;2% of lung cancer cases. Currently, Positron Emission Tomography (PET)/CT based on the radiolabeled sugar analogue [<sup>18</sup>F]-FDG is used to diagnose and stage pulmonary carcinoids, but is subo...

Full description

Bibliographic Details
Main Authors: Rachael E. Guenter, Tolulope Aweda, Danilea M. Carmona Matos, Jason Whitt, Alexander W. Chang, Eric Y. Cheng, X. Margaret Liu, Herbert Chen, Suzanne E. Lapi, Renata Jaskula-Sztul
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:Cancers
Subjects:
somatostatin receptor
histone deacetylase inhibitor
neuroendocrine cancer
pulmonary carcinoid
Online Access:https://www.mdpi.com/2072-6694/11/6/767

Internet

https://www.mdpi.com/2072-6694/11/6/767

Similar Items